New Approaches for the Management of Diabetes: Practical Considerations for Clinicians

1
New Approaches for the Management of Diabetes
Practical Considerations for Clinicians
2
SGLT2 Inhibitors in Phase 3 Trials
3
(No Transcript)
4
(No Transcript)
5
(No Transcript)
6
Dapagliflozin Reduction in FPG at Week 24
Across Studies
7
Dapagliflozin 10 mg vs Metformin XR vs
Combination Therapy HbA1c at Week 24
8
Dapagliflozin 10 mg vs Glipizide as Add-on to
Metformin
9
Dapagliflozin Change in Body Weight at Week 24
10
(No Transcript)
11
(No Transcript)
12
Summary Efficacy of SGLT2 Inhibitors
13
Elements of Decision-Making for Achieving
Glycemic Goals
14
ADA / EASD Position StatementManaging
Hyperglycemia in T2DM
15
Abbreviations
16
Abbreviations (cont)
17
Abbreviations (cont)
18
References
19
References (cont)
20
References (cont)
21
References (cont)
22
References (cont)
23
References (cont)
24
References (cont)
25
References (cont)
26
References (cont)